Рекомендации по ведению взрослых больных с кашлем

1. Schappert S.M. National ambulatory medical care survey: 1991 summary. Adv. Data 1993; 230: 1–16.

2. McGarvey L.P.A., Heaney L.G., MacMahon J. A retrospective survey of diagnosis and management of patients presenting with chronic cough to a general chest clinic. Int. J. Clin. Pract. 1998; 52: 158–161.

3. Birring S.S., Prudon B., Carr A.J. et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003; 58: 339–343.

4. French C. T, Irwin R.S., Fletcher K.E. et al. Evaluation of cough-specific quality of life questionnaire. Chest 2002; 121: 1123–1131.

5. Irwin R.S. et al. Diagnosis and management of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 1s–292s.

6. Morice A.H., Fontana G.A., Sovijarvi A.R.A. et al. The diagnosis and management of chronic cough. Eur. Respir. J. 2004; 24: 481–492.

7. Anon. Cough guidelines choke on evidence. Lancet 2006; 367: 276.

8. Widdicombe J., Fontana G. Cough: what’s in a name? Eur. Respir. J. 2006; 28: 10–15.

9. Curley F.J., Irwin R.S., Pratter M.R. et al. Cough and the common cold. Am. Rev. Respir. Dis. 1988; 138: 305–311.

10. Irwin R.S., Boulet L.P., Cloutier M.M. et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998; 114: 133S–181S.

11. Johnston S.L., Holgate S.T. Epidemiology of respiratory tract infections. In: Myint S., Taylor-Robinson D., eds. Viral other infections of the human respiratory tract. London: Chapman & Hall, 1996.

12. Reid D.D., Williams R.E., Hirch A. Colds among office workers, an epidemiological study. Lancet 1953; 265: 1303–1306.

13. Eccles R., Loose I., Jawad M. et al. Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Med. 2003; 4: 118–124.

14. Proprietary Association of Great Britain (PAGB). Annual review and report 2002. London: Proprietary Association of Great Britain; 2002: 1–30.

15. Office of Population Censuses and Surveys. Morbidity statistics from general practice: 4th national study 1991–1992, series MB5, 3. London: HMSO, 1995.

16. Morice A.H. Epidemiology of cough. Pulm. Pharmacol. Ther. 2002; 15: 253–259.

17. Schaberg T., Gialdroni-Grassi G., Huchon G. et al. An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory Society. Thorax 1996; 51: 1017–1022.

18. Loudon R.G. Weather and cough. Am. Rev. Respir. Dis. 1964; 89: 352–359.

19. Monto A.S., Gravenstein S., Elliott M. et al. Clinical signs and symptoms predicting influenza infection. Arch. Intern. Med. 2000; 160: 3243–3247.

20. Fleming D., Harcourt S., Smith G. Influenza and adult hospital admissions for respiratory conditions in England 1989–2001. Commun. Dis. Publ. Hlth 2003; 6: 231–237.

21. Fendrick A.M., Monto A.S., Nightengale B. et al. The economic burden of noninfluenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003; 163: 487–494.

22. Bramley T.J., Lerner D., Sames M. Productivity losses related to the common cold. J. Occup. Environ. Med. 2002; 44: 822–829.

23. Gwaltney J.M. Jr., Phillips C.D., Miller R.D. et al. Computed tomographic study of the common cold. N. Engl. J. Med. 1994; 330: 25–30.

24. Puhakka T., Lavonius M., Varpula M. et al. Pulmonary imaging and function in the common cold. Scand. J. Infect. Dis. 2001; 33: 211–214.

25. Hutchings H.A., Eccles R., Smith A.P. et al. Voluntary cough suppression as an indication of symptom severity in upper respiratory tract infections. Eur. Respir. J. 1993; 6: 1449–1454.

26. Parvez L., Vaidya M., Sakhardande A. et al. Evaluation of antitussive agents in man. Pulm. Pharmacol. Ther. 1996; 9: 299–308.

27. Manap R.A., Wright C.E., Gregory A. et al. The antitussive effect of dextromethorphan in relation to CYP2D6 activity. Br. J. Clin. Pharmacol. 1999; 48: 382–387.

28. Morice A.H., Marshall A.E., Higgins K.S. et al. Effect of inhaled menthol on citric acid induced cough in normal subjects. Thorax 1994; 49: 1024–1026.

29. Janson C., Chinn S., Jarvis D. et al. Determinants of cough in young adults participating in the European Community Respiratory Health Survey. Eur. Respir. J. 2001; 18: 647–654.

30. Barbee R.A., Halonen M., Kaltenborn W.T. et al. A longitudinal study of respiratory symptoms in a community population sample. Correlations with smoking, allergen skintest reactivity, and serum IgE. Chest 1991; 99: 20–26.

31. Cullinan P. Persistent cough and sputum: prevalence and clinical characteristics in south east England. Respir. Med. 1992; 86: 143–149.

32. Lundback B., Nystrom L., Rosenhall L. et al. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur. Respir. J. 1991; 4: 257–266.

33. Ford A.C., Forman D., Moayyedi P. et al. Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax 2006 (epub ahead of print).

34. Bjornsson E., Plaschke P., Norrman E. et al. Symptoms related to asthma and chronic bronchitis in three areas of Sweden. Eur. Respir. J. 1994; 7: 2146–2153.

35. Ludviksdottir D., Bjornsson E., Janson C. et al. Habitual coughing and its associations with asthma, anxiety, and gastroesophageal reflux. Chest 1996; 109: 1262–1268.

36. Fujimura M., Kasahara K., Kamio Y. et al. Female gender as a determinant of cough threshold to inhaled capsaicin. Eur. Respir. J. 1996; 9: 1624–1626.

37. Kastelik J.A., Thompson R.H., Aziz I. et al. Sex-related differences in cough reflex sensitivity in patients with chronic cough. Am. J. Respir. Crit. Care Med. 2002; 166: 961–964.

38. Turner D., Wailoo A., Nicholson K. et al. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Hlth. Technol. Assess 2003; 7: iii–xiii.

39. Zemp E., Elsasser S., Schindler C. et al. Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team. Am. J. Respir. Crit. Care Med. 1999; 159: 1257–1266.

40. Braun-Fahrlander C., Wuthrich B., Gassner M. et al. Validation of a rhinitis symptom questionnaire (ISAAC core questions) in a population of Swiss school children visiting the school health services. SCARPOL team. Swiss Study on Childhood Allergy and Respiratory Symptom with Respect to Air Pollution and Climate. International Study of Asthma and Allergies in Childhood. Pediatr. Allergy Immunol. 1997; 8: 75–82.

41. Vedal S., Petkau J., White R. et al. Acute effects of ambient inhalable particles in asthmatic and nonasthmatic children. Am. J. Respir. Crit. Care Med. 1998; 157: 1034–1043.

42. Montnemery P., Bengtsson P., Elliot A. et al. Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group. Respir. Med. 2001; 95: 744–752.

43. Viegi G., Pedreschi M., Baldacci S. et al. Prevalence rates of respiratory symptoms and diseases in general population samples of North and Central Italy. Int. J. Tuberc. Lung Dis. 1999; 3: 1034–1042.

44. Gehring U., Heinrich J., Jacob B. et al. Respiratory symptoms in relation to indoor exposure to mite and cat allergens and endotoxins. Indoor Factors and Genetics in Asthma (INGA) Study Group. Eur. Respir. J. 2001; 18: 555–563.

45. French C.L., Irwin R.S., Curley F.J. et al. Impact of chronic cough on quality of life. Arch. Intern. Med. 1998; 158: 1657–1661.

46. Dicpinigaitis P.V., Tso R. Prevalence of depressive symptoms in patients with chronic cough (abstract). Proc. Am. Thorac. Soc. 2005; 2: A520.

47. French C.T., Fletcher K.E., Irwin R.S. A comparison of gender differences in health-related quality of life in acute and chronic coughers. Chest 2005; 127: 1991–1998.

48. French C.T., Fletcher K.E., Irwin R.S. Gender differences in health-related quality of life in patients complaining of chronic cough. Chest 2004; 125: 482–488.

49. Birring S.S., Patel R.B., Prudon B. et al. Quality of life in chronic cough (abstract). Am. J. Respir. Crit. Care Med. 2003; 167: A135.

50. Morice A.H., Kastelik J.A. Cough – 1: Chronic cough in adults. Thorax 2003; 58: 901–907.

51. Jansen D.F., Schouten J.P., Vonk J.M. et al. Smoking and airway hyperresponsiveness especially in the presence of blood eosinophilia increase the risk to develop respiratory symptoms: a 25-year follow-up study in the general adult population. Am. J. Respir. Crit. Care Med. 1999; 160: 259–264.

52. Dicpinigaitis P.V. Cough reflex sensitivity in cigarette smokers. Chest 2003; 123: 685–688.

53. Mello C.J., Irwin R.S., Curley F.J. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch. Intern. Med 1996; 156: 997–1003.

54. Everett C.F., Ojoo J.C., Thompson R.H. et al. A questionnaire survey of individuals complaining of chronic cough (abstract). Am. J. Respir. Crit. Care Med. 2003; 167 (suppl.): A316.

55. McGarvey L.P., Heaney L.G., Lawson J.T. et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998; 53: 738–743.

56. Ojoo J.C., Kastelik J.A., Morice A.H. A boy with a disabling cough. Lancet 2003; 361: 674.

57. O’Connell F., Thomas V.E., Studham J.M. et al. Capsaicin cough sensitivity increases during upper respiratory infection. Respir. Med. 1996; 90: 279–286.

58. Cerveri I., Accordini S., Corsico A. et al. Chronic cough and phlegm in young adults. Eur. Respir. J. 2003; 22: 413–417.

59. Power J.T., Stewart I.C., Connaughton J.J. et al. Nocturnal cough in patients with chronic bronchitis and emphysema. Am. Rev. Respir. Dis. 1984; 130: 999–1001.

60. Hsu J.Y., Stone R.A., Logan Sinclair R.B. et al. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur. Respir. J. 1994; 7: 1246–1253.

61. Hargreaves M., Channon K. Mechanism of pacemaker induced cough. Br. Heart J. 1994; 71: 484–486.

62. Raj H., Singh V.K., Anand A. et al. Sensory origin of lobeline-induced sensations: a correlative study in man and cat. J. Physiol. Lond. 1995; 482: 235–246.

63. Morice A.H., Lowry R., Brown M.J. et al. Angiotensin converting enzyme and the cough reflex. Lancet 1987; 2: 1116–1118.

64. Bonnet R., Jorres R., Downey R. et al. Intractable cough associated with the supine body position. Effective therapy with nasal CPAP. Chest 1995; 108: 581–585.

65. Mittal R.K., Balaban D.H. The esophagogastric junction. N. Engl. J. Med. 1997; 336: 924–932.

66. Everett C.F., Morice A.H. Clinical history in gastroesophageal cough. Respir. Med. 2006 (epub ahead of print).

67. Sesoko S., Kaneko Y. Cough associated with the use of captopril. Arch. Intern. Med. 1985; 145: 1524.

68. Yeo W.W., Foster G., Ramsay L.E. Prevalence of persistent cough during longterm enalapril treatment: controlled study versus nifedipine. Quart. J. Med. 1991; 80: 763–770.

69. Morimoto T., Gandhi T.K., Fiskio JM, et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J. Eval. Clin. Pract. 2004; 10: 499–509.

70. Ojoo J.C., Kastelik J.A., Morice A.H. Duration of angiotensin converting enzyme inhibitor (ACEI) induced cough (abstract). Thorax 2001; 56 (suppl. III): iii72.

71. Pitt B., Segal R., Martinez F.A. et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349: 747–752.

72. Peyriere H., Mauboussin J.M., Arnaud A. et al. Chronic cough induced by abacavir apart from a context of hypersensitivity. Allerg. Immunol. (Paris) 2002; 34: 359–360.

73. Isler M., Akhan G., Bardak Y. et al. Dry cough and optic neuritis: two rare complications of interferon alpha treatment in chronic viral hepatitis. Am. J. Gastroenterol. 2001; 96: 1303–1304.

74. Kern J., Mustajbegovic J., Schachter E.N. et al. Respiratory findings in farmworkers. J. Occup. Environ. Med. 2001; 43: 905–913.

75. Gordon S.B., Curran A.D., Wong C.H. et al. Chronic respiratory symptom excess in bottle factory workers. Eur. Respir. J. 1996; 9: 23s.

76. Blanc P., Liu D., Juarez C. et al. Cough in hot pepper workers. Chest 1991; 99: 27–32.

77. Pauwels R.A., Buist A.S., Ma P. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir. Care 2001; 46: 798–825.

78. Smyrnios N.A., Irwin R.S., Curley F.J. Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest 1995; 108: 991–997.

79. Hopwood P., Stephens R.J. Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br. J. Cancer. 1995; 71: 633–636.

80. Bergman B., Aaronson N.K., Ahmedzai S. et al. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQC30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur. J. Cancer. 1994; 30A: 635–642.

81. Galdi E., Moscato G. Pertussis in the aetiology of chronic cough in adults. Monaldi Arch. Chest Dis. 2002; 57: 229–230.

82. Birkebaek N.H., Kristiansen M., Seefeldt T. et al. Bordetella pertussis and chronic cough in adults. Clin. Infect. Dis. 1999; 29: 1239–1242.

83. Jansen D.F., Rijcken B., Schouten J.P. et al. The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to symptomatic and asymptomatic airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 1999; 159: 924–931.

84. Fujimura M., Ogawa H., Nishizawa Y. et al. Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax 2003; 58: 14–18.

85. McGarvey L., Morice A.H. Atopic cough: little evidence to support a new clinical entity. Thorax 2003; 58: 736–737.

86. Haider A.W., Larson M.G., O’Donnell C.J. et al. The association of chronic cough with the risk of myocardial infarction: the Framingham Heart Study. Am. J. Med. 1999; 106: 279–284.

87. Birring S.S., Brightling C.E., Symon F.A. et al. Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax 2003; 58: 1066–1070.

88. Kok C., Kennerson M.L., Spring P.J. et al. A locus for hereditary sensory neuropathy with cough and gastroesophageal reflux on chromosome 3p22–p24. Am. J. Hum. Genet. 2003; 73: 632–637.

89. McGarvey L.P., Heaney L.G., Lawson J.T. et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998; 53: 738–743.

90. Birring S.S., Passant C., Patel R.B. et al. Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough. Eur. Respir. J. 2004; 23: 199–201.

91. Koufman J.A. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101: 1–78.

92. Thiadens H.A., De Bock G.H., Dekker F.W. et al. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study. Br. Med. J. 1998; 316: 1286–1290.

93. Yu M.L., Ryu J.H. Assessment of the patient with chronic cough (see comment). Mayo Clin. Proc. 1997; 72: 957–959.

94. Lawler W.R. An office approach to the diagnosis of chronic cough. Am. Fam. Physician 1998; 58: 2015–2022.

95. D’Urzo A, Jugovic P. Chronic cough. Three most common causes. Can. Fam. Physician 2002; 48: 1311–1316.

96. Irwin R.S., Corrao W.M., Pratter M.R. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am. Rev. Respir. Dis. 1981; 123: 413–417.

97. Poe R.H., Harder R.V., Israel R.H. et al. Chronic persistent cough. Experience in diagnosis and outcome using an anatomic diagnostic protocol. Chest 1989; 95: 723–728.

98. Irwin R.S., Curley F.J., French C.L. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am. Rev. Respir. Dis. 1990; 141: 640–647.

99. Pratter M.R., Bartter T., Akers S. et al. An algorithmic approach to chronic cough. Ann. Intern. Med. 1993; 119: 977–983.

100. Palombini B.C., Villanova C.A., Araujo E. et al. A pathogenic triad in chronic cough: asthma, postnasal drip syndrome, and gastroesophageal reflux disease. Chest 1999; 116: 279–284.

101. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23: 932–946.

102. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003; 58 (suppl. I): i1–i94.

103. Cockcroft D.W., Jokic R., Marciniuk D.D. et al. The current dilemma with spirometric inclusion criteria for asthma drug trials. Ann. Allergy Asthma Immunol. 1997; 79: 226–228.

104. Thiadens H.A., De Bock G.H., Van Houwelingen J.C. et al. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV 1 in primary care patients presenting with a persistent cough? Thorax 1999; 54: 1055–1060.

105. Corrao W.M., Braman S.S., Irwin R.S. Chronic cough as the sole presenting manifestation of bronchial asthma. N. Engl. J. Med. 1979; 300: 633–637.

106. Gibson P.G., Dolovich J., Denburg J. et al. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989; 1: 1346–1348.

107. Hunter C.J., Brightling C.E., Woltmann G. et al. A comparison of the validity of different diagnostic tests in adults with asthma. Chest 2002; 121: 1051–1057.

108. Puolijoki H., Lahdensuo A. Causes of prolonged cough in patients referred to a chest clinic. Ann. Med. 1989; 21: 425–427.

109. Al-Mobeireek A.F., Al-Sarhani A., Al-Amri S. et al. Chronic cough at a nonteaching hospital: are extrapulmonary causes overlooked? Respirology 2002; 7: 141–146.

110. Kastelik J.A., Aziz I., Ojoo J.C. et al. Investigation and management of chronic cough using a probability-based algorithm. Eur. Respir. J. 2005; 25: 235–243.

111. Mise K., Sviliicic A., Bradaric A. Foreign bodies in the bronchial system of adults (abstract). Eur. Respir. J. 2004; 24 (suppl.): 48s.

112. Poe R.H., Israel R.H., Utell M.J. et al. Chronic cough: bronchoscopy or pulmonary function testing? Am. Rev. Respir. Dis. 1982; 126: 160–162.

113. Packham S. The role of bronchoscopy in the mangement of chronic cough (abstract). Eur. Respir. J. 2001; 18 (suppl. 33): 378s.

114. Sen R.P., Walsh T.E. Fiberoptic bronchoscopy for refractory cough. Chest 1991; 99: 33–35.

115. El Hennawi D.D., Iskander N.M., Ibrahim I.H. et al. Persistent cough: prevalence of gastroesophageal reflux and study of relevant laryngeal signs. Otolaryngol. Head. Neck. Surg. 2004; 131: 767–772.

116. Packham S. The sensitivity of high resolution computed tomography and flexible bronchoscopy in the diagnosis of chronic cough (abstract). Eur. Respir. J. 2002; 20 (suppl.): 450s.

117. Ojoo J.C., Kastelik J.A., Mulrennan S.A. Selective use of thoracic computed tomographs in patients with chronic cough (abstract). Eur. Respir. J. 2002; 20 (suppl.): 449s.

118. Padley S.P, Hansell D.M., Flower C.D. et al. Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease. Clin. Radiol. 1991; 44: 222–226.

119. van der Bruggen-Bogaarts B.A., van der Bruggen H.M., van Waes P.F. et al. Screening for bronchiectasis. A comparative study between chest radiography and high-resolution CT. Chest 1996; 109: 608–611.

120. Volpe J., Storto M.L., Lee K. et al. High-resolution CT of the lung: determination of the usefulness of CT scans obtained with the patient prone based on plain radiographic findings. Am. J. Roentgenol. 1997; 169: 369–374.

121. Irwin R.S., Madison J.M. The diagnosis and treatment of cough. N. Engl. J. Med. 2000; 343: 1715–1721.

122. Fitch P.S., Brown V., Schock B.C. et al. Chronic cough in children: bronchoalveolar lavage findings. Eur. Respir. J. 2000; 16: 1109–1114.

123. Higgins B.G., Britton J.R., Chinn S. et al. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am. Rev. Respir. Dis. 1992; 145: 588–593.

124. Brightling C.E., Ward R., Goh K.L. et al. Eosinophilic bronchitis is an important cause of chronic cough. Am. J. Respir. Crit. Care Med. 1999; 160: 406–410.

125. Brightling C.E., Bradding P., Symon F.A. et al. Mast cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 2002; 346: 1699–1705.

126. Pavord I.D., Brightling C.E., Woltmann G. et al. Noneosinophilic corticosteroid unresponsive asthma (letter]. Lancet 1999; 353: 2213–2214.

127. Green R.H., Brightling C.E., Woltmann G. et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57: 875–879.

128. Cheriyan S., Greenberger P.A., Patterson R. Outcome of cough variant asthma treated with inhaled steroids. Ann. Allergy 1994; 73: 478–480.

129. Dicpinigaitis P.V., Dobkin J.B., Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. J. Asthma 2002; 39: 291–297.

130. Rafferty P., Jackson L., Smith R. et al. Terfenadine, a potent histamine H1-receptor antagonist in the treatment of grass pollen sensitive asthma. Br. J. Clin. Pharmacol. 1990; 30: 229–235.

131. Brightling C.E., Ward R., Wardlaw A.J. et al. Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur. Respir. J. 2000; 15: 682–686.

132. Braman S.S., Corrao W.M. Chronic cough. Diagnosis and treatment. Prim. Care 1985; 12: 217–225.

133. Koh Y.Y., Jeong J.H., Park Y. et al. Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness. Eur. Respir. J. 1999; 14: 302–308.

134. Hancox R.J., Leigh R., Kelly M.M. et al. Eosinophilic bronchitis. Lancet 2001; 358: 1104.

135. O’Connell F., Thomas V.E., Studham J.M. et al. Capsaicin cough sensitivity increases during upper respiratory infection. Respir. Med. 1996; 90: 279–286.

136. Ferrari M., Olivieri M., Sembenini C. et al. Tussive effect of capsaicin in patients with gastroesophageal reflux without cough. Am. J. Respir. Crit. Care Med. 1995; 151: 557–561.

137. Benini L., Ferrari M., Sembenini C. et al. Cough threshold in reflux oesophagitis: influence of acid and of laryngeal and oesophageal damage. Gut. 2000; 46: 762–767.

138. Chernow B., Johnson L.F., Janowitz W.R. et al. Pulmonary aspiration as a consequence of gastroesophageal reflux: a diagnostic approach. Dig. Dis. Sci. 1979; 24: 839–844.

139. Corwin R.W., Irwin R.S. The lipid-laden alveolar macrophage as a marker of aspiration in parenchymal lung disease. Am. Rev. Respir. Dis. 1985; 132: 576–581.

140. Crausaz F.M., Favez G. Aspiration of solid food particles into lungs of patients with gastroesophageal reflux and chronic bronchial disease. Chest 1988; 93: 376–378.

141. Irwin R.S., French C.L., Curley F.J. et al. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 1993; 104: 1511–1517.

142. Giudicelli R., Dupin B., Surpas P. et al. Gastroesophageal reflux and respiratory manifestations: diagnostic approach, therapeutic indications and results (in French). Ann. Chir. 1990; 44: 552–554.

143. Ing A.J., Ngu M.C., Breslin A.B. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am. J. Respir. Crit. Care Med. 1994; 149: 160–167.

144. Patti M.G., Debas H.T., Pellegrini C.A. Esophageal manometry and 24-hour pH monitoring in the diagnosis of pulmonary aspiration secondary to gastroesophageal reflux. Am. J. Surg. 1992; 163: 401–406.

145. DeMeester T.R., Bonavina L., Iascone C. et al. Chronic respiratory symptoms and occult gastroesophageal reflux. A prospective clinical study and results of surgical therapy. Ann. Surg. 1990; 211: 337–345.

146. Fouad Y.M., Katz P.O., Hatlebakk J.G. et al. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am. J. Gastroenterol. 1999; 94: 1464–1467.

147. Knight R.E., Wells J.R., Parrish R.S. Esophageal dysmotility as an important cofactor in extraesophageal manifestations of gastroesophageal reflux. Laryngoscope 2000; 110: 1462–1466.

148. Kastelik J.A., Redington A.E., Aziz I. et al. Abnormal oesophageal motility in patients with chronic cough. Thorax 2003; 58: 699–702.

149. Ing A.J., Ngu M.C., Breslin A.B. Chronic persistent cough and clearance of esophageal acid. Chest 1992; 102: 1668–1671.

150. Kastelik J.A., Jackson W., Davies T.W. et al. Measurement of gastric emptying in gastroesophageal reflux-related chronic cough. Chest 2002; 122: 2038–2041.

151. Ing A.J., Ngu M.C., Breslin A.B. Chronic persistent cough and gastrooesophageal reflux. Thorax 1991; 46: 479–483.

152. Ours T.M., Kavuru M.S., Schilz R.J. et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am. J. Gastroenterol. 1999; 94: 3131–3138.

153. Kiljander T.O., Salomaa E.R., Hietanen E.K. et al. Chronic cough and gastrooesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur. Respir. J. 2000; 16: 633–638.

154. Ing A.J., Ngu M.C., Breslin A.B. A randomised double-blind placebo controlled crossover study of ranitidine in patients with chronic persistent cough associated with gastroesophageal reflux. Am. Rev. Respir. Dis. 1992; 145: A11.

155. Vaezi M.F., Richter J.E. Twenty-four-hour ambulatory esophageal pH monitoring in the diagnosis of acid refluxrelated chronic cough. South Med. J. 1997; 90: 305–311.

156. Kamel P.L., Hanson D., Kahrilas P.J. Omeprazole for the treatment of posterior laryngitis. Am. J. Med. 1994; 96: 321–326.

157. Kuo B., Castell D.O. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am. J. Gastroenterol. 1996; 91: 1532–1538.

158. Xue S., Katz P.O., Banerjee P. et al. Bedtime H 2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment. Pharmacol. Ther. 2001; 15: 1351–1356.

159. Nilsson M., Johnsen R., Ye W. et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. J. A. M. A. 2003; 290: 66–72.

160. Novitsky Y.W., Zawacki J.K., Irwin R.S. et al. Chronic cough due to gastroesophageal reflux disease: efficacy of antireflux surgery. Surg. Endosc. 2002; 16: 567–571.

161. Menon M.S., Mulrennan S.A., Everett C.F. et al. Experience with baclofen in cough secondary to gastrooesophageal reflux disease (abstract). Proc. Am. Thorac. Soc. 2005; 2: A323.

162. Dicpinigaitis P.V. Effect of the GABA-agonist baclofen on bronchial responsiveness in asthmatics. Pulm. Pharmacol. Ther. 1999; 12: 257–260.

163. Allen C.J., Anvari M. Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication. Thorax 1998; 53: 963–968.

164. Allen C.J., Anvari M. Preoperative symptom evaluation and esophageal acid infusion predict response to laparoscopic Nissen fundoplication in gastroesophageal reflux patients who present with cough. Surg. Endosc. 2002; 16: 1037–1041.

165. Irwin R.S., Zawacki J.K., Wilson M.M. et al. Chronic cough due to gastroesophageal reflux disease: failure to resolve despite total/near-total elimination of esophageal acid. Chest 2002; 121: 1132–1140.

166. Morice A.H. Post-nasal drip syndrome-a symptom to be sniffed at? Pulm. Pharmacol. Ther. 2004; 17: 343–345.

167. Tanaka S., Hirata K., Kurihara N. et al. Effect of loratadine, an H1 antihistamine, on induced cough in non-asthmatic patients with chronic cough. Thorax 1996; 51: 810–814.

168. Dicpinigaitis P.V., Gayle Y.E. Effect of the second-generation antihistamine fexofenadine on cough reflex sensitivity and pulmonary function. Br. J. Clin. Pharmacol 2003; 56: 501–504.

169. Gawchik S., Goldstein S., Prenner B. et al. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Ann. Allergy Asthma Immunol. 2003; 90: 416–421.

170. Puhakka T., Makela M.J., Malmstrom K. et al. The common cold: effects of intranasal fluticasone propionate treatment. J. Allergy Clin. Immunol. 1998; 101: 726–731.

171. O’Connell F., Thomas V.E., Pride N.B. et al. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am. J. Respir. Crit. Care Med. 1994; 150: 374–380.

172. Birring S.S., Murphy A.C., Scullion J.E. et al. Idiopathic chronic cough and organ-specific autoimmune diseases: a case-control study. Respir. Med. 2004; 98: 242–246.

173. Haque R.A., Usmani O.S., Barnes P.J. Chronic idiopathic cough: a discrete clinical entity? Chest 2005; 127: 1710–1713.

174. Mund E., Christensson B., Gronneberg R. et al. Noneosinophilic CD4 lymphocytic airway inflammation in menopausal women with chronic dry cough. Chest 2005; 127: 1714–1721.

175. Prudon B., Birring S.S., Vara D.D. et al. Cough and glotticstop reflex sensitivity in health and disease. Chest 2005; 127: 550–557.

176. Lee S.Y., Cho J.Y., Shim J.J. et al. Airway inflammation as an assessment of chronic nonproductive cough. Chest 2001; 120: 1114–1120.

177. Boulet L.P., Milot J., Boutet M. et al. Airway inflammation in nonasthmatic subjects with chronic cough. Am. J. Respir. Crit. Care Med. 1994; 149: 482–489.

178. McGarvey L.P., Forsythe P., Heaney L.G. et al. Bronchoalveolar lavage findings in patients with chronic nonproductive cough. Eur. Respir. J. 1999; 13: 59–65.

179. Niimi A., Torrego A., Nicholson A.G. et al. Nature of airway inflammation and remodeling in chronic cough. J. Allergy Clin. Immunol. 2005; 116: 565–570.

180. Birring S.S., Parker D., Brightling C.E. et al. Induced sputum inflammatory mediator concentrations in chronic cough. Am. J. Respir. Crit. Care Med. 2004; 169: 15–19.

181. Mund E., Christensson B., Larsson K. et al. Sex dependent differences in physiological ageing in the immune system of lower airways in healthy nonsmoking volunteers: study of lymphocyte subsets in bronchoalveolar lavage fluid and blood. Thorax 2001; 56: 450–455.

182. Birring S.S., Pavord I.D. Idiopathic chronic cough and organ-specific autoimmune disease. Chest 2006; 129: 213–214.

183. Birring S.S., Patel R.B., Parker D. et al. Airway function and markers of airway inflammation in patients with treated hypothyroidism. Thorax 2005; 60: 249–253.

184. Brightling C.E., Symon F.A., Birring S.S. et al. A case of cough, lymphocytic bronchoalveolitis and coeliac disease with improvement following a gluten free diet. Thorax 2002; 57: 91–92.

185. Birring S.S., Morgan C.N., Prudon B. et al. Respiratory symptoms in patients with treated hypothyroidism and inflammatory bowel disease. Thorax 2003; 58: 533–536.

186. Raphael J.H., Stanley G.D., Langton J.A. Effects of topical benzocaine and lignocaine on upper airway reflex sensitivity. Anaesthesia 1996; 51: 114–118.

187. Jackson J., Wright C.E., Menon M. et al. Opiate therapy in chronic intractable cough (abstract). Proc. Am. Thorac. Soc. 2005; 2: A321.

188. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59 (suppl. I): 1–232.

189. Muers M.F., Round C.E. Palliation of symptoms in nonsmall cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax 1993; 48: 339–343.

190. Crystal R.G., Fulmer J.D., Roberts W.C. et al. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann. Intern. Med. 1976; 85: 769–788.

191. Hope-Gill B.D., Hilldrup S., Davies C. et al. A study of the cough reflex in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2003; 168: 995–1002.

192. Carney I.K., Gibson P.G., Murree-Allen K. et al. A systematic evaluation of mechanisms in chronic cough. Am. J. Respir. Crit. Care Med. 1997; 156: 211–216.

193. Lin L., Poh K.L., Lim T.K. Empirical treatment of chronic cough: a cost effectiveness analysis. Proc. AMIA Symp. 2001: 383–387.

194. Chung K.F., Lalloo U.G. Diagnosis and management of chronic persistent dry cough. Postgrad. Med. J. 1996; 72: 594–598.

195. Kim C.K., Kim J.T., Kang H. et al. Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma. Clin. Exp. Allergy 2003; 33: 1409–1414.

196. Gibson P.G., Hargreave F.E., Girgis-Gabardo A. et al. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin. Exp. Allergy 1995; 25: 127–132.

197. Irwin R.S., Pratter M.R., Holland P.S. et al. Postnasal drip causes cough and is associated with reversible upper airway obstruction. Chest 1984; 85: 346–352.

198. Bucca C., Rolla G., Brussino L. et al. Are asthma-like symptoms due to bronchial or extrathoracic airway dysfunction? Lancet 1995; 346: 791–795.

199. Patterson R.N., Johnston B.T., MacMahon J. et al. Oesophageal pH monitoring is of limited value in the diagnosis of ‘‘reflux-cough’’. Eur. Respir. J. 2004; 24: 724–727.

200. Sifrim D., Holloway R., Silny J. et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pHimpedance recording. Gastroenterology 2001; 120: 1588–1598.

201. Davidson T.M., Brahme F.J., Gallagher M.E. Radiographic evaluation for nasal dysfunction: computed tomography versus plain films. Head Neck Surg. 1989; 11: 405–409.

202. Belafsky P.C., Postma G.N., Koufman J.A. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001; 111: 1313–1317.

203. Dicpinigaitis P.V. Shortand long-term reproducibility of capsaicin cough challenge testing. Pulm. Pharmacol. Ther. 2003; 16: 61–65.

204. Morice A.H., Kastelik J.A., Thompson R. Cough challenge in the assessment of cough reflex. Br. J. Clin. Pharmacol. 2001; 52: 365–375.

205. Chang A.B., Newman R.G., Carlin J.B. et al. Subjective scoring of cough in children: parent-completed vs childcompleted diary cards vs an objective method. Eur. Respir. J. 1998; 11: 462–466.

206. Coyle M.A., Keenan B.D., Mayleben D.W. et al. Objective assessment of cough over a 24-hr period in patients with COPD (abstract). Am. J. Respir. Crit. Care Med. 2004: A606.

207. Chang A.B., Newman R.G., Phelan P.D. et al. A new use for an old Holter monitor: an ambulatory cough meter. Eur. Respir. J. 1997; 10: 1637–1639.

208. Corrigan D.L., Paton J.Y. Pilot study of objective cough monitoring in infants. Pediatr. Pulmonol. 2003; 35: 350–357.

209. Munyard P., Bush A. How much coughing is normal? Arch. Dis. Child. 1996; 74: 531–534.

210. Piirila P., Sovijarvi A.R. Differences in acoustic and dynamic characteristics of spontaneous cough in pulmonary diseases. Chest 1989; 96: 46–53.

211. Hall L.E., Smith A., Earis J.E. et al. Patterns of cough in cystic fibrosis and cryptogenic fibrosing alveolitis (abstract). Thorax 2001; 56 (Suppl III): iii71.

212. McGarvey L., Heaney L., MacMahon J. et al. Eosinophilic bronchitis is an important cause of chronic cough (letter). Am. J. Respir. Crit. Care Med. 2000; 161: 1763–1764.

213. Chatkin J.M., Ansarin K., Silkoff P.E. et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am. J. Respir. Crit. Care Med. 1999; 159: 1810–1813.

214. Formanek W., Inci D., Lauener R.P. et al. Elevated nitrite in breath condensates of children with respiratory disease. Eur. Respir. J. 2002; 19: 487–491.

215. Adcock J.J., Schneider C., Smith T.W. Effects of codeine, morphine and a novel opioid pentapeptide BW443C, on cough, nociception and ventilation in the unanaesthetized guinea-pig. Br. J. Pharmacol. 1988; 93: 93–100.

216. Mcleod R.L., Parra L.E., Mutter J.C. et al. Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors. Br. J. Pharmacol. 2001; 132: 1175–1178.

217. Bolser D.C., Mcleod R.L., Tulshian D.B. et al. Antitussive action of nociceptin in the cat. Eur. J. Pharmacol. 2001; 430: 107–111.

218. Advenier C., Girard V., Naline E. et al. Antitussive effect of SR 48968, a nonpeptide tachykinin NK(2) receptor antagonist. Eur. J. Pharmacol. 1993; 250: 169–171.

219. Girard V., Naline E., Vilain P. et al. Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea-pig. Eur. Respir. J. 1995; 8: 1110–1114.

220. Ichinose M., Nakajima N., Takahashi T. et al. Protection against bradykinininduced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 1992; 340: 1248–1251.

221. Fahy J.V., Wong H.H., Geppetti P. et al. Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic salineinduced bronchoconstriction and cough in male asthmatic subjects. Am. J. Respir. Crit. Care Med. 1995; 152: 879–884.

222. Daoui S., Cognon C., Naline E. et al. Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea pigs. Am. J. Respir. Crit. Care Med. 1998; 158: 42–48.

223. Hay D.W., Giardina G.A., Griswold D.E. et al. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acidinduced cough and airways hyper-reactivity in guinea pigs. J. Pharmacol. Exp. Ther. 2002; 300: 314–323.

224. Bolser D.C., Aziz S.M., DeGennaro F.C. et al. Antitussive effects of GABAB agonists in the cat and guinea-pig. Br. J. Pharmacol. 1993; 110: 491–495.

225. Bolser D.C., DeGennaro F.C., O’Reilly S. et al. Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig. Br. J. Pharmacol. 1994; 113: 1344–1348.

226. Dicpinigaitis P.V., Dobkin J.B., Rauf K. et al. Inhibition of capsaicin-induced cough by the gamma-aminobutyric acid agonist baclofen. J. Clin. Pharmacol. 1998; 38: 364–367.

227. Dicpinigaitis P.V., Dobkin J.B. Antitussive effect of the GABA-agonist baclofen. Chest 1997; 111: 996–999.

228. Patel H.J., Birrell M.A., Crispino N. et al. Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br. J. Pharmacol. 2003; 140: 261–268.

229. Choudry N.B., Fuller R.W., Anderson N. et al. Separation of cough and reflex bronchoconstriction by inhaled local anaesthetics. Eur. Respir. J. 1990; 3: 579–583.

230. McKemy D.D., Neuhausser W.M., Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002; 416: 52–58.

231. Caterina M.J., Schumacher M.A., Tominaga M. et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816–824.

232. Caterina M.J., Leffler A., Malmberg A.B. et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288: 306–313.

233. Lalloo U.G., Fox A.J., Belvisi M.G. et al. Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J. Appl. Physiol. 1995; 79: 1082–1087.

234. Groneberg D.A., Niimi A., Dinh .T. et al. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am. J. Respir. Crit. Care Med. 2004; 170: 1276–1280.

235. Fox A.J., Barnes P.J., Venkatesan P. et al. Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. J. Clin. Invest 1997; 99: 513–519.